<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liang Q</submitter><funding>Open Foundation of Shandong Provincial Key Laboratory of Oral Tissue Regeneration</funding><funding>National Key R&amp;D Program of China</funding><funding>National Natural Science Foundation of China</funding><funding>Collaborative Innovation Center of Technology and Equipment for Biological Diagnosis and Therapy in Universities of Shandong, The National Key Research and Development Program of China</funding><funding>Construction Engineering Special Fund of "Taishan Scholars" of Shandong Province</funding><pagination>e12997</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7941242</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>54(3)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Stromal cell-derived factor-1 (SDF-1) actively directs endogenous cell homing. Exendin-4 (EX-4) promotes stem cell osteogenic differentiation. Studies revealed that EX-4 strengthened SDF-1-mediated stem cell migration. However, the effects of SDF-1 and EX-4 on periodontal ligament stem cells (PDLSCs) and bone regeneration have not been investigated. In this study, we aimed to evaluate the effects of SDF-1/EX-4 cotherapy on PDLSCs in vitro and periodontal bone regeneration in vivo.&lt;h4>Methods&lt;/h4>Cell-counting kit-8 (CCK8), transwell assay, qRT-PCR and western blot were used to determine the effects and mechanism of SDF-1/EX-4 cotherapy on PDLSCs in vitro. A rat periodontal bone defect model was developed to evaluate the effects of topical application of SDF-1 and systemi</pubmed_abstract><journal>Cell proliferation</journal><pubmed_title>Stromal cell-derived factor-1/Exendin-4 cotherapy facilitates the proliferation, migration and osteogenic differentiation of human periodontal ligament stem cells in vitro and promotes periodontal bone regeneration in vivo.</pubmed_title><pmcid>PMC7941242</pmcid><funding_grant_id>81873716</funding_grant_id><funding_grant_id>2017YFA0104604</funding_grant_id><funding_grant_id>SDKQ201901</funding_grant_id><funding_grant_id>tsqn201909180</funding_grant_id><funding_grant_id>SDKQ201904</funding_grant_id><funding_grant_id>81670993</funding_grant_id><funding_grant_id>2017YFB0405400</funding_grant_id><funding_grant_id>ts20190975</funding_grant_id><pubmed_authors>Ge S</pubmed_authors><pubmed_authors>Kang W</pubmed_authors><pubmed_authors>Du L</pubmed_authors><pubmed_authors>Zhang R</pubmed_authors><pubmed_authors>Liang Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Stromal cell-derived factor-1/Exendin-4 cotherapy facilitates the proliferation, migration and osteogenic differentiation of human periodontal ligament stem cells in vitro and promotes periodontal bone regeneration in vivo.</name><description>&lt;h4>Objectives&lt;/h4>Stromal cell-derived factor-1 (SDF-1) actively directs endogenous cell homing. Exendin-4 (EX-4) promotes stem cell osteogenic differentiation. Studies revealed that EX-4 strengthened SDF-1-mediated stem cell migration. However, the effects of SDF-1 and EX-4 on periodontal ligament stem cells (PDLSCs) and bone regeneration have not been investigated. In this study, we aimed to evaluate the effects of SDF-1/EX-4 cotherapy on PDLSCs in vitro and periodontal bone regeneration in vivo.&lt;h4>Methods&lt;/h4>Cell-counting kit-8 (CCK8), transwell assay, qRT-PCR and western blot were used to determine the effects and mechanism of SDF-1/EX-4 cotherapy on PDLSCs in vitro. A rat periodontal bone defect model was developed to evaluate the effects of topical application of SDF-1 and systemi</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-18T18:58:09.933Z</modification><creation>2025-04-07T06:43:19.788Z</creation></dates><accession>S-EPMC7941242</accession><cross_references><pubmed>33511708</pubmed><doi>10.1111/cpr.12997</doi></cross_references></HashMap>